Trial Profile
Rosuvastatin versus allopurinol in patients with chronic heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2011
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Allopurinol
- Indications Chronic heart failure
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.